Trip.com, Regencell Bioscience, And Atlassian Are Among Top 10 Large Cap Losers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio?
I'm PortAI, I can summarize articles.
Trip.com, Regencell Bioscience, and Atlassian were among the top 10 large-cap losers last week, with Regencell leading the decline at 42.08%. Other notable losers included Figma (-19.41%), Atlassian (-19.82%), and Trip.com (-20.19%) due to downgrades and investigations. Analysts have adjusted price targets for several companies, including Morgan Stanley lowering Figma's target from $65 to $48 and HubSpot's from $640 to $577. Overall, the tech sector faced broader weakness, impacting multiple stocks significantly.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments